for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Steris PLC

STE

Latest Trade

188.76USD

Change

0.43(+0.23%)

Volume

402,361

Today's Range

187.06

 - 

189.54

52 Week Range

105.69

 - 

203.91

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
188.33
Open
187.64
Volume
402,361
3M AVG Volume
8.18
Today's High
189.54
Today's Low
187.06
52 Week High
203.91
52 Week Low
105.69
Shares Out (MIL)
85.35
Market Cap (MIL)
16,074.43
Forward P/E
30.91
Dividend (Yield %)
0.85

Next Event

Q3 2021 Steris plc Earnings Release

Latest Developments

More

Steris Announces Definitive Agreement To Acquire Cantel Medical

Steris Announces Financial Results For Fiscal 2021 Second Quarter

Steris PLC Says Signed Definitive Agreement To Purchase Key Surgical Of Water Street Healthcare Partners Through U.S. Subsidiary For $850 Million

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Steris PLC

Steris plc, formerly Steris Ltd, is a provider of infection prevention and other procedural products and services. The Company offers a mix of capital equipment products, such as sterilizers and washers, surgical tables, lights and equipment management systems and connectivity solutions, such as operating room integration; consumable products, such as detergents and gastrointestinal endoscopy accessories and other products; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory services and outsourced reprocessing. The Company operates through four reportable business segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. It’s Corporate and other segment includes the Defense and Industrial business unit. The Company serves the customers in the United Kingdom, the United States and many other countries throughout the world.

Industry

Medical Equipment & Supplies

Contact Info

Block a Riverside IV

70 Sir John Rogerson's Quay

2

Ireland

+353.1.2322000

https://www.steris.com/

Executive Leadership

Mohsen M. Sohi

Independent Chairman of the Board

Walter M. Rosebrough

President, Chief Executive Officer, Director

Michael J. Tokich

Chief Financial Officer, Senior Vice President

Daniel A. Carestio

Chief Operating Officer, Senior Vice President

J. Adam Zangerle

Senior Vice President, General Counsel, Secretary

Key Stats

2.17 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

2.6K

2019

2.8K

2020

3.0K

2021(E)

3.1K
EPS (USD)

2018

4.150

2019

4.890

2020

5.640

2021(E)

6.092
Price To Earnings (TTM)
38.22
Price To Sales (TTM)
5.32
Price To Book (MRQ)
4.40
Price To Cash Flow (TTM)
25.68
Total Debt To Equity (MRQ)
27.98
LT Debt To Equity (MRQ)
27.98
Return on Investment (TTM)
8.62
Return on Equity (TTM)
7.90

Latest News

Latest News

BRIEF-FDA Issues Second Emergency Use Authorization To Decontaminate N95 Respirators

* FDA ISSUES SECOND EMERGENCY USE AUTHORIZATION TO DECONTAMINATE N95 RESPIRATORS

BRIEF-Steris Reports Q4 Earnings Per Share Of $0.86

* Q4 EARNINGS PER SHARE VIEW $1.22, REVENUE VIEW $704.9 MILLION -- THOMSON REUTERS I/B/E/S

BRIEF-Steris PLC Says Co, Steris Corp Have Entered Into A Credit Agreement Dated March 23, 2018

* STERIS PLC SAYS CO, STERIS CORPORATION HAVE ENTERED INTO A CREDIT AGREEMENT DATED MARCH 23, 2018 - SEC FILING

BRIEF-Steris PLC Reports QTRLY GAAP EPS Of $1.11

* FISCAL 2018 THIRD QUARTER REVENUE AS REPORTED WAS $661.9 MILLION COMPARED WITH $646.8 MILLION IN THE THIRD QUARTER OF FISCAL 2017

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up